MissionIR Articles

Aastrom Biosciences, Inc. develops patient-specific cell products for treating severe, chronic ischemic cardiovascular diseases. The company is developing ixmyelocel-T, a multicellular therapy expanded from a patient’s own bone marrow and delivered directly to damaged tissues.…

Cancer Genetics, Inc. is an early-stage diagnostics company developing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to the treatment of cancer. The company’s tests target many cancers, including…

Oxygen Biotherapeutics, Inc. is a development stage company developing biotechnology products that deliver oxygen to target tissues in the body. The company develops Oxycyte, an oxygen carrier for use in situations of acute ischemia, which…

Invivo Therapeutics Holdings Corp. (OTCBB: NVIV) is a development stage company engaged in the development and commercialization of biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.…

Amarin Corporation plc is a biopharmaceutical company engaged in developing and bringing to market therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and the therapeutic benefits of…

Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues for research and medical applications. The company’s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the…

BioSpecifics Technologies Corp. (NASDAQ: BSTC) is a biopharmaceutical company that is focused on developing an injectable collagenase for various clinical indications. Under the XIAFLEX name, BioSpecifics provides injectable collagenase for the treatment of adult Dupuytren’s…

Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. Its lead product candidate includes APPY1, a blood-based diagnostic test designed to aid in the evaluation of patients for acute appendicitis. The company,…

SciClone Pharmaceuticals, Inc. provides therapies for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in China and internationally. Its principal product is ZADAXIN, which is used for the treatment…

Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company that engages in identifying, developing and bringing to market therapies for multiple sclerosis (MS), spinal cord injury and other central nervous system disorders. Acorda’s products include: Ampyra (dalfampridine), a…

Advanced Cell Technology, Inc. is a biotechnology company that develops human embryonic and adult stem cell technology. The company has ownership/licensing of approximately 37 patents and approximately 190 patent applications pending in the regenerative medicine…

Alcobra Ltd. is an emerging biopharmaceutical company that develops and markets drugs for the treatment of central nervous system disorders and cognitive dysfunctions. The company is primarily focused on developing and marketing its most advanced…

Champions Oncology, Inc. offers technology solutions that personalize the development and use of oncology drugs. The company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in…

Spectrum Pharmaceuticals, Inc. is a biotechnology company engaged in acquiring, developing, and marketing prescription drug products for hematology and oncology. The company’s oncology products include FUSILEV for patients with osteosarcoma after high-dose methotrexate therapy; FOLOTYN,…

OncoSec Medical Incorporated (ONCS) OncoSec Medical Incorporated (OTC: ONCS) designs and develops novel cancer therapeutic products. The company’s products combine proprietary delivery technology with a novel DNA-based immunotherapeutics, known as OMS ElectroOncology. Its clinical programs…

Heat Biologics, Inc. is a biopharmaceutical company developing cellular therapeutic vaccines for cancers and infectious diseases. The company is developing the Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are…

NeoStem, Inc. develops proprietary cell therapy products. It is involved in: manufacturing cell therapy-based products; product and process development; cell and tissue processing; regulatory support, storage, distribution and delivery; and consulting services. The company also…

Inovio Pharmaceuticals, Inc. (NYSE: INO) and its subsidiaries engage in discovering and developing synthetic vaccines and immune therapies for cancers and other infectious diseases. Inovio’s DNA-based SynCon technology facilitates the design of vaccines capable of…

Kips Bay Medical, Inc. (NASDAQ: KIPS) is a medical device company that manufactures its external saphenous vein support technology (eSVS Mesh) for use in coronary artery bypass grafting (CABG) surgery. Its eSVS Mesh is a…

Fluoropharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FPMI’s initial focus is the development of breakthrough positron…